CMHDF (China Resources Medical Holdings Co) Growth Rank: 9 (As of Aug. 02, 2026) — 13% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CMHDF China Resources Medical Holdings Co Ltd CMHDF
88 GF Score
Price $0.58
GF Value $0.93
! 5 Warning Signs
View Full Analysis

What is China Resources Medical Holdings Co Growth Rank?

China Resources Medical Holdings Co CMHDF 88 Growth Rank is 9 as of Aug. 02, 2026, which is 13% above its 10-year median of 8.00. GuruFocus rates CMHDF with a GF Score™ of 88/100 and a GF Value™ of $0.93. The stock has 5 warning signs investors should review.

China Resources Medical Holdings Co has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

China Resources Medical Holdings Co Growth Rank Related Terms

CMHDF vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resources Medical Holdings Co Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's Growth Rank distribution charts can be found below:

* The bar in red indicates where China Resources Medical Holdings Co's Growth Rank falls into.


CMHDF
88GF Score
China Resources Medical Holdings Co Ltd CMHDF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 9 mean?
China Resources Medical Holdings Co (CMHDF) has a Growth Rank of 9 as of Aug. 02, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on China Resources Medical Holdings Co and its competitors. This is 13% above median its historical median of 8.00. Over the past decade, China Resources Medical Holdings Co's Growth Rank has ranged from 1.00 to 10.00.
Is China Resources Medical Holdings Co's Growth Rank too high?
China Resources Medical Holdings Co's current Growth Rank of 9 is 13% above median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, China Resources Medical Holdings Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Growth Rank compare to HCA and THC?
China Resources Medical Holdings Co's Growth Rank of 9 can be compared against companies in the Healthcare Providers & Services industry. Historically, China Resources Medical Holdings Co's own Growth Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on China Resources Medical Holdings Co and its competitors. China Resources Medical Holdings Co's current Growth Rank is 9, which is 13% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Growth Rank of 9. The stock's GF Value™ is $0.93, compared to a current price of $0.58 — trading 37.6% below its estimated fair value. The current Growth Rank is 9, which is 13% above median its 10-year median of 8.00. China Resources Medical Holdings Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Growth Rank is 9 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued. The current stock price of $0.58 is trading 37.6% below its estimated GF Value™ of $0.93.

Key valuation signals for CMHDF:

  • Growth Rank: 9 (13% above median its 10-year median of 8.00)
  • GF Value™: $0.93 vs. price of $0.58 (37.6% below fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Resources Medical Holdings Co Business Description

Other Exchanges 01515:Hong Kong1PH:Germany
Address No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
88GF Score

Get the complete analysis for CMHDF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$0.93
GF Value